Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.


Listen to the latest hemonc news from international experts

The impact of AI and machine learning algorithms in MDS

Artificial intelligence (AI) and machine learning algorithms are transforming treatment and prognosis in hematological malignancies, as well as other areas of medicine. AI is becoming increasingly important for managing large data sets and patient information and is being explored in a number of areas. Despite the growing interest and promise of AI and machine learning algorithms in a medical setting, there are many challenges associated with applying these in a clinical setting, and questions that still need to be answered.

In this exclusive podcast, Amer Zeidan, MBBS, MHS, of Yale University and Yale Cancer Center, New Haven, CT, Aziz Nazha, MD, of the Thomas Jefferson University, Philadelphia, PA, and Anne Sophie Kubasch, MD, of Leipzig University Hospital, Leipzig, Germany, hold a fascinating discussion on the impact of artificial intelligence and machine learning in myelodysplastic syndromes (MDS).

Date: 13th May 2022

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter